Alzheimer's disease (AD) is one of the most concerning neurodegenerative diseases. As a global leading CRO company focusing on neuroscience research, Creative Biolabs has an advanced technology platform providing various kinds of AD in vitro disease model services to help accelerate AD studies.
Creative Biolabs is the specialist provider of an AD biomarker assay. We have a professional team of scientists to provide a comprehensive range of rapid AD Biomarker assays through standard experimental procedures to meet the different needs of AD research.
Creative Biolabs is always the leader in 3D neural spheroids culture technology services and offers a variety of technologies to help you grow 3D neural spheroids quickly and efficiently. In addition, we also provide functional tests and a one-stop service for your research and development to bring more physiological relevance.
Recombinant monoclonal antibody to BAFF. Tabalumab (LY 2127399) is an anti-B-cell activating factor (BAFF) human monoclonal antibody designed for the treatment of autoimmune diseases and B cell malignancies.
CD79B (CD79b Molecule) is a Protein Coding gene. Diseases associated with CD79B include Agammaglobulinemia 6, Autosomal Recessive and Agammaglobulinemia, Non-Bruton Type. Among its related pathways are Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers and Innate Immune System. Gene Ontology (GO) annotations related to this gene include transmembrane signaling receptor activity. Learn more: cd79b marker.
At Creative Biolabs, total complement activity tests are respectively carried out by CH50 for the complement classical pathway, AH50 for the complement alternative pathway, and LP50 for the complement lectin pathway. Among the tests, CH50 and AH50 assays are based on the complement hemolytic activity detection while the LP50 is based on the enzyme immunoassay of the terminal complement complex detection. All test procedures are shown as follows, both a one-stop test for all three pathways and a test for any one pathway based on the client’s demands are all available. Learn more: hemolytic assay complement
Creative Biolabs has always been interested in the development of a novel drug delivery system, which aims to deliver the drug at a rate directed by the needs of the body during the period of treatment, and channel the active entity to the site of action. In recent years, vesicles have become the vehicle of choice in drug delivery. Having worked in the field of bioactives delivery for many years, Creative Biolabs has developed comprehensive sets of innovative and diversified drug delivery platforms based on vesicular system. At present, we are able to provide a full range of services and customized products concerning versatile carrier. Learn more: Vesicular system-based drug delivery.
With the unlimited proliferative capacity and extensive differentiation potential, human pluripotent stem cells (hPSCs) present distinct advantages than adult stem cells. In order to avoid the ethical issues, the application of human embryonic stem cell (hES cells) is replaced by human induced pluripotent stem cells (hiPSCs). which can be generated from various adult somatic cell types via the introduction of four specific transcription factors: OCT3/4, SOX2, KLF4, and c-MYC. However, these hiPSCs cannot be used directly into patients because of the tumorigenic potential. In this case, a differentiation protocol is an essential prerequisite to direct hiPSCs into specific cell types. As such, the neural differentiation of hiPSCs enables a promising cell source for both regenerative medicine and cell therapy. Learn more: neural stem cells.
MUC16, well known as CA125 (carbohydrate antigen 125 or cancer antigen 125), is a member of the mucin family glycoprotein ranked as the largest membrane-associated mucin with about 22,000 amino acids, which is initially detected by the murine monoclonal antibody designated OC125 (the 125th Ab produced against the ovarian cancer cell line) and named " cancer antigen 125". It consists of a cytoplasmic tail for the interaction with cytoskeleton, a transmembrane domain and several extracellular domains including a highly O-glycosylated N-terminal domain, a tandem repeat (high in serine, threonine and proline) and multiple SEA (sea urchin sperm protein, enterokinase and agrin) modules, which contain a proteolytic cleavage site for release of extracellular region from the cell surface. Learn more: anti-MUC16 CAR-T in vivo assay.
Product Name: Bee Venom Extract From V.vulgaris & V. germanica Mixture Product Description: This venom extract is a mix of Vespula vulgaris and Vespula germanica. Vespula vulgaris and Vespula germanica both belong to the Vespidae family and the Hymenoptera order. The product can be used for applications such as a diagnostic marker, investigate the development of venom allergy, and develop a therapy against venom allergy. This product is for research use only.